Plasma samples with gross lipaemia present a challenge for coagulation laboratories using optical analysers. High-speed centrifugation may be used to remove excess lipids but it has not established whether this affects haemostasis tests.
| INTRODUC TI ON
Lipaemic plasma samples are commonly encountered in hospital diagnostic laboratories. Excessive lipaemia can increase turbidity in plasma samples due to an excess of large lipoprotein particles, especially chylomicrons. 1 Consequently, plasma samples with lipaemia present a challenge for clinical laboratories using optical analysers since light scatter and absorption may be increased resulting in reduced light transmission. 2 This may result in instrument error flags, requiring visual inspection of coagulation curves or, in the presence of gross lipaemia, instrument vote-outs (ie no result is generated).
Lipaemia may be the result of postprandial blood lipid changes or following lipid infusions in critically ill patients. In these cases, a repeat sample taken from a fasting patient or prior to lipid infusion may eliminate the problem, 3 but this leads to delay in obtaining results, which could delay diagnosis or treatment. However, if the lipaemia is due to a medical/metabolic condition (eg familial hypertriglyceridaemia, diabetes mellitus, renal and liver disease), repeat testing will not eliminate the problem. In these cases, the only alternative is retesting with a mechanical coagulometer or manual tube tilt-tube method in a water bath. However, many clinical laboratories do not have the facilities to do this.
Several methods have been proposed to reduce optical interference due to lipaemia, including ultracentrifugation (>60 000 g); high-speed centrifugation (8000-20 000 g); and lipid extraction using organic solvents or lipid-clearing agents. The Clinical and Laboratory Standards Institute (CLSI) 4 states that "ultracentrifugation has been suggested in some circumstances; however, although there is anecdotal evidence to suggest that this is widely used in haemostasis laboratories, there are no published studies." Ultracentrifugation is unavailable to most clinical laboratories, and furthermore, it may result in the loss of high molecular weight analytes such as fibrinogen, the FVIII/von Willebrand factor complex and D-dimer. 2 We propose a simple high-speed centrifugation method to reduce the level of lipaemia to a level which allows testing on an optical analyser without substantially altering the test results in a range of haemostasis parameters. For the statistical analysis (Table 1) , the results of prespin lipaemic samples and prespiked plasmas were combined into a single group and compared with the results of postlipid depletion plasmas. Results for lipaemic samples which did not produce results before centrifugation were excluded from the analysis for the test that was affected. No significant differences in fibrinogen, D-dimer, VWF Ac or VWF:RCo were observed. PT and APTT results were slightly shorter but, although the differences were statistically significant, they were too small to be of clinical significance (Table 1) . Excellent correlation was observed for all tests ( Figure 2 ). 
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| D ISCUSS I ON
TA B L E 1
Median results for plasmas prior to and after lipid reduction by highspeed centrifugation. Only those results with both pre-and postlipid reduction values were included in the analysis lipoproteins by ultracentrifugation. However, there are no published data to support the use of ultracentrifugation for haemostasis and it is not available to most diagnostic laboratories. The only study to use an organic solvent (n-hexane) for haemostasis samples found significant changes in both PT and APTT. 6 We have investigated the use of high-speed centrifugation to The triglyceride levels in many of the samples would not have been expected to influence VWF levels, based on the manufacturer interference values. However, it was useful to include VWF measurement as well as fibrinogen and D-dimer, to demonstrate that high-speed centrifugation did not remove these large, multidomain proteins.
High-speed centrifugation at 10 000 g reduced turbidity sufficiently to allow a range of commonly requested haemostasis tests in all 46 lipaemic and spiked samples, including those that did not Correlation between haemostasis test results before and after lipid reduction was excellent in all six parameters. Although the reduction in triglyceride and cholesterol was modest, the reduction in turbidity, as assessed by visual inspection and elimination of instrument vote-outs, was manifested. This would suggest that the largest lipoprotein particles were preferentially removed by high-speed centrifugation as previously reported. 5 Our data show that if a result is obtained by the coagulometer, then that result does not change after reduction of lipid; thus, only samples that do not yield a result require high-speed centrifugation. The limitations of our study were that only one haemostasis analyser with a single set of reagents was studied. The technique described will therefore require validation for other analyser types and reagents. We believe that this simple method for reducing optical interference due to lipaemia may be suitable for most diagnostic laboratories.
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